BusinessAxsome Therapeutics Announces Primary Endpoint Met in Phase 1 Trial of Next Generation Product Candidate AXS-09 Containing Chirally Pure Esbupropion and DextromethorphanBy Nasdaq OMXFeb 26, 2018, 12:00 PM UTC
BusinessAchillion Announces ACH-4471 Receives Positive Opinion for Orphan Drug Designation in the European Union for the Treatment of C3 GlomerulopathyBy Nasdaq OMXFeb 26, 2018, 11:05 AM UTC
BusinessArbutus Settles Litigation, Terminating Acuitas’ Rights to LNP TechnologyBy Nasdaq OMXFeb 22, 2018, 9:35 PM UTC
BusinessNew Published Study Reports Cardiosphere-Derived Cells Improved Skeletal and Cardiac Muscle Function in Mouse Model of Duchenne Muscular DystrophyBy Nasdaq OMXFeb 22, 2018, 6:22 PM UTC
BusinessAchillion Announces Restructuring to Advance Corporate Strategy; Announces 2017 Fourth Quarter and Full Year Financial ResultsBy Nasdaq OMXFeb 22, 2018, 11:05 AM UTC
BusinessUtah’s Life Sciences Industry One of the Fastest Growing in the U.S., Powering Utah’s Economic GrowthBy Nasdaq OMXFeb 21, 2018, 4:00 PM UTC
BusinessApricus Biosciences Announces Corporate Update, Fourth Quarter and Full Year 2017 Financial Results Conference CallBy Nasdaq OMXFeb 21, 2018, 12:01 PM UTC
BusinessSynthego Named One of World’s Top 10 Most Innovative Companies in Biotech by Fast CompanyBy Nasdaq OMXFeb 20, 2018, 5:03 PM UTC
